• Health & Medicine

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment

A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care. A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.

31 August 2017

• Health & Medicine

Targeted radiotherapy limits side effects of breast cancer treatment

Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment. Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment.

2 August 2017

• Science & Technology

Stem cell treatment kills cancer cells that have spread in mice

A new stem cell-based cancer treatment can target and kill breast cancer cells that have spread in mice, according to a new study. A new stem cell-based cancer treatment can target and kill breast cancer cells that have spread in mice, according to a new study.

27 July 2017

• Science & Technology
• Health & Medicine

Study estimates breast and ovarian cancer risk linked to faulty BRCA genes

A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer. A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.

20 June 2017

• Science & Technology
• Health & Medicine

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine. Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

19 June 2017

• Health & Medicine

Breast cancer drug approved for NHS England

The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer. The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.

16 June 2017

• Health & Medicine

Combining immunotherapies could benefit some aggressive breast cancers

Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study. Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.

8 June 2017

• Health & Medicine

New chemotherapy approach offers breast cancer patients a better quality of life

The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF

6 June 2017

• Health & Medicine

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy. A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

4 June 2017

• Health & Medicine

Alcohol and breast cancer – how big is the risk?

A new report on breast cancer risk has made the headlines - but what does the evidence say? A new report on breast cancer risk has made the headlines - but what does the evidence say?

25 May 2017

• Science & Technology
• Health & Medicine

Preventing unnecessary breast cancer treatment

Our scientists want to help doctors give women with DCIS a definitive answer on their individual risk of developing breast cancer. So they know, once and for all, if treatment is necessary. Our scientists want to help doctors give women with DCIS a definitive answer on their individual risk of developing breast cancer. So they know, once and for all, if treatment is necessary.

24 May 2017

• Health & Medicine

Taking a potential new breast cancer treatment from the lab to the clinic

Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer. Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.

5 May 2017